NAMI
PCVX icon

Nomura Asset Management International’s Vaxcyte PCVX Stock Holding History

Nomura Asset Management International’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Hold
20,000
– – ﹤0.01% 1188
2026
Q1 		$1.16M Hold
20,000
– – ﹤0.01% 1085
2025
Q4 		$923K Buy
+20,000
New +$895K ﹤0.01% 1111

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nomura Asset Management International's PCVX Position: Q2 2026 in Review

Nomura Asset Management International held its Vaxcyte (PCVX) position steady in Q2 2026 at 20,000 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Nomura Asset Management International first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. 330 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Nomura Asset Management International held 20,000 shares of Vaxcyte worth $1.16M as of Q2 2026.
  • Nomura Asset Management International left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1188 holding.
  • Nomura Asset Management International first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
  • 330 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.